---
title: "Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285118718.md"
description: "Bristol Myers Squibb Co. (BMY) shares fell 1.44% to $57.38 on Monday, marking its second consecutive day of losses. The stock is now 8.76% below its 52-week high of $62.89. In comparison, competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories also experienced declines. The S&P 500 Index and Dow Jones Industrial Average fell by 0.41% and 1.13%, respectively, indicating a poor trading session overall."
datetime: "2026-05-04T20:37:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285118718.md)
  - [en](https://longbridge.com/en/news/285118718.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285118718.md)
---

# Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) shed 1.44% to $57.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,200.75 and Dow Jones Industrial Average falling 1.13% to 48,941.90.

This was the stock's second consecutive day of losses.

Bristol Myers Squibb Co. closed 8.76% below its 52-week high of $62.89, which the company achieved on March 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 1.32% to $224.20, Pfizer Inc. (PFE) fell 0.11% to $26.30, and Abbott Laboratories (ABT) fell 2.15% to $87.54.

Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-04-26 1637ET

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [RXL.US](https://longbridge.com/en/quote/RXL.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Bristol Myers Squibb Company $BMY Stock Position Raised by Legato Capital Management LLC](https://longbridge.com/en/news/287428008.md)
- [BMS and Anthropic collaborate for Claude implementation](https://longbridge.com/en/news/287194781.md)
- [BMY Stock Rises as Bristol Myers Brings Anthropic's Claude AI to 30,000 Employees](https://longbridge.com/en/news/287076466.md)
- [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md)
- [BUZZ-Relay Therapeutics gains after $275 mln equity raise](https://longbridge.com/en/news/287216991.md)